<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mohamed H</submitter><funding>Drexel University Office of Global Engagement and Education Abroad</funding><funding>Drexel University College of Medicine, Department of Microbiology &amp;amp; Immunology and Institute for Molecular Medicine and Infectious Disease</funding><funding>German Federal Ministry of Education and Research</funding><pagination>e0247125</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7920340</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(3)</volume><pubmed_abstract>Effective control of infection by human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome (AIDS), requires continuous and life-long use of anti-retroviral therapy (ART) by people living with HIV-1 (PLWH). In the absence of ART, HIV-1 reemergence from latently infected cells is ineffectively suppressed due to suboptimal innate and cytotoxic T lymphocyte responses. However, ART-free control of HIV-1 infection may be possible if the inherent immunological deficiencies can be reversed or restored. Herein we present a novel approach for modulating the immune response to HIV-1 that involves the use of non-thermal plasma (NTP), which is an ionized gas containing various reactive oxygen and nitrogen species (RONS). J-Lat cells were used as a model</pubmed_abstract><journal>PloS one</journal><pubmed_title>Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection.</pubmed_title><pmcid>PMC7920340</pmcid><funding_grant_id>03Z22DN11</funding_grant_id><funding_grant_id>03Z22DN12</funding_grant_id><funding_grant_id>03Z22Di1</funding_grant_id><pubmed_authors>Freund E</pubmed_authors><pubmed_authors>Connors J</pubmed_authors><pubmed_authors>Dampier W</pubmed_authors><pubmed_authors>Bekeschus S</pubmed_authors><pubmed_authors>Haddad EK</pubmed_authors><pubmed_authors>Wigdahl B</pubmed_authors><pubmed_authors>Clemen R</pubmed_authors><pubmed_authors>Lackmann JW</pubmed_authors><pubmed_authors>Wende K</pubmed_authors><pubmed_authors>Miller V</pubmed_authors><pubmed_authors>Mohamed H</pubmed_authors><pubmed_authors>Krebs FC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection.</name><description>Effective control of infection by human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome (AIDS), requires continuous and life-long use of anti-retroviral therapy (ART) by people living with HIV-1 (PLWH). In the absence of ART, HIV-1 reemergence from latently infected cells is ineffectively suppressed due to suboptimal innate and cytotoxic T lymphocyte responses. However, ART-free control of HIV-1 infection may be possible if the inherent immunological deficiencies can be reversed or restored. Herein we present a novel approach for modulating the immune response to HIV-1 that involves the use of non-thermal plasma (NTP), which is an ionized gas containing various reactive oxygen and nitrogen species (RONS). J-Lat cells were used as a model</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-09T01:15:27.083Z</modification><creation>2021-03-13T08:21:23Z</creation></dates><accession>S-EPMC7920340</accession><cross_references><pubmed>33647028</pubmed><doi>10.1371/journal.pone.0247125</doi></cross_references></HashMap>